Cargando…

Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers

OBJECTIVES: Established visual brain MRI markers for dementia include hippocampal atrophy (mesio-temporal atrophy MTA), white matter lesions (Fazekas score), and number of cerebral microbleeds (CMBs). We assessed whether novel quantitative, artificial intelligence (AI)–based volumetric scores provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannakopoulos, Panteleimon, Montandon, Marie-Louise, Herrmann, François R., Hedderich, Dennis, Gaser, Christian, Kellner, Elias, Rodriguez, Cristelle, Haller, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668758/
https://www.ncbi.nlm.nih.gov/pubmed/35486172
http://dx.doi.org/10.1007/s00330-022-08798-0
_version_ 1784831983136800768
author Giannakopoulos, Panteleimon
Montandon, Marie-Louise
Herrmann, François R.
Hedderich, Dennis
Gaser, Christian
Kellner, Elias
Rodriguez, Cristelle
Haller, Sven
author_facet Giannakopoulos, Panteleimon
Montandon, Marie-Louise
Herrmann, François R.
Hedderich, Dennis
Gaser, Christian
Kellner, Elias
Rodriguez, Cristelle
Haller, Sven
author_sort Giannakopoulos, Panteleimon
collection PubMed
description OBJECTIVES: Established visual brain MRI markers for dementia include hippocampal atrophy (mesio-temporal atrophy MTA), white matter lesions (Fazekas score), and number of cerebral microbleeds (CMBs). We assessed whether novel quantitative, artificial intelligence (AI)–based volumetric scores provide additional value in predicting subsequent cognitive decline in elderly controls. METHODS: A prospective study including 80 individuals (46 females, mean age 73.4 ± 3.5 years). 3T MR imaging was performed at baseline. Extensive neuropsychological assessment was performed at baseline and at 4.5-year follow-up. AI-based volumetric scores were derived from 3DT1: Alzheimer Disease Resemblance Atrophy Index (AD-RAI), Brain Age Gap Estimate (BrainAGE), and normal pressure hydrocephalus (NPH) index. Analyses included regression models between cognitive scores and imaging markers. RESULTS: AD-RAI score at baseline was associated with Corsi (visuospatial memory) decline (10.6% of cognitive variability in multiple regression models). After inclusion of MTA, CMB, and Fazekas scores simultaneously, the AD-RAI score remained as the sole valid predictor of the cognitive outcome explaining 16.7% of its variability. Its percentage reached 21.4% when amyloid positivity was considered an additional explanatory factor. BrainAGE score was associated with Trail Making B (executive functions) decrease (8.5% of cognitive variability). Among the conventional MRI markers, only the Fazekas score at baseline was positively related to the cognitive outcome (8.7% of cognitive variability). The addition of the BrainAGE score as an independent variable significantly increased the percentage of cognitive variability explained by the regression model (from 8.7 to 14%). The addition of amyloid positivity led to a further increase in this percentage reaching 21.8%. CONCLUSIONS: The AI-based AD-RAI index and BrainAGE scores have limited but significant added value in predicting the subsequent cognitive decline in elderly controls when compared to the established visual MRI markers of brain aging, notably MTA, Fazekas score, and number of CMBs. KEY POINTS: • AD-RAI score at baseline was associated with Corsi score (visuospatial memory) decline. • BrainAGE score was associated with Trail Making B (executive functions) decrease. • AD-RAI index and BrainAGE scores have limited but significant added value in predicting the subsequent cognitive decline in elderly controls when compared to the established visual MRI markers of brain aging, notably MTA, Fazekas score, and number of CMBs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-08798-0.
format Online
Article
Text
id pubmed-9668758
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96687582022-11-18 Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers Giannakopoulos, Panteleimon Montandon, Marie-Louise Herrmann, François R. Hedderich, Dennis Gaser, Christian Kellner, Elias Rodriguez, Cristelle Haller, Sven Eur Radiol Neuro OBJECTIVES: Established visual brain MRI markers for dementia include hippocampal atrophy (mesio-temporal atrophy MTA), white matter lesions (Fazekas score), and number of cerebral microbleeds (CMBs). We assessed whether novel quantitative, artificial intelligence (AI)–based volumetric scores provide additional value in predicting subsequent cognitive decline in elderly controls. METHODS: A prospective study including 80 individuals (46 females, mean age 73.4 ± 3.5 years). 3T MR imaging was performed at baseline. Extensive neuropsychological assessment was performed at baseline and at 4.5-year follow-up. AI-based volumetric scores were derived from 3DT1: Alzheimer Disease Resemblance Atrophy Index (AD-RAI), Brain Age Gap Estimate (BrainAGE), and normal pressure hydrocephalus (NPH) index. Analyses included regression models between cognitive scores and imaging markers. RESULTS: AD-RAI score at baseline was associated with Corsi (visuospatial memory) decline (10.6% of cognitive variability in multiple regression models). After inclusion of MTA, CMB, and Fazekas scores simultaneously, the AD-RAI score remained as the sole valid predictor of the cognitive outcome explaining 16.7% of its variability. Its percentage reached 21.4% when amyloid positivity was considered an additional explanatory factor. BrainAGE score was associated with Trail Making B (executive functions) decrease (8.5% of cognitive variability). Among the conventional MRI markers, only the Fazekas score at baseline was positively related to the cognitive outcome (8.7% of cognitive variability). The addition of the BrainAGE score as an independent variable significantly increased the percentage of cognitive variability explained by the regression model (from 8.7 to 14%). The addition of amyloid positivity led to a further increase in this percentage reaching 21.8%. CONCLUSIONS: The AI-based AD-RAI index and BrainAGE scores have limited but significant added value in predicting the subsequent cognitive decline in elderly controls when compared to the established visual MRI markers of brain aging, notably MTA, Fazekas score, and number of CMBs. KEY POINTS: • AD-RAI score at baseline was associated with Corsi score (visuospatial memory) decline. • BrainAGE score was associated with Trail Making B (executive functions) decrease. • AD-RAI index and BrainAGE scores have limited but significant added value in predicting the subsequent cognitive decline in elderly controls when compared to the established visual MRI markers of brain aging, notably MTA, Fazekas score, and number of CMBs. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-022-08798-0. Springer Berlin Heidelberg 2022-04-29 2022 /pmc/articles/PMC9668758/ /pubmed/35486172 http://dx.doi.org/10.1007/s00330-022-08798-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Neuro
Giannakopoulos, Panteleimon
Montandon, Marie-Louise
Herrmann, François R.
Hedderich, Dennis
Gaser, Christian
Kellner, Elias
Rodriguez, Cristelle
Haller, Sven
Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers
title Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers
title_full Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers
title_fullStr Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers
title_full_unstemmed Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers
title_short Alzheimer resemblance atrophy index, BrainAGE, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing MR imaging markers
title_sort alzheimer resemblance atrophy index, brainage, and normal pressure hydrocephalus score in the prediction of subtle cognitive decline: added value compared to existing mr imaging markers
topic Neuro
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668758/
https://www.ncbi.nlm.nih.gov/pubmed/35486172
http://dx.doi.org/10.1007/s00330-022-08798-0
work_keys_str_mv AT giannakopoulospanteleimon alzheimerresemblanceatrophyindexbrainageandnormalpressurehydrocephalusscoreinthepredictionofsubtlecognitivedeclineaddedvaluecomparedtoexistingmrimagingmarkers
AT montandonmarielouise alzheimerresemblanceatrophyindexbrainageandnormalpressurehydrocephalusscoreinthepredictionofsubtlecognitivedeclineaddedvaluecomparedtoexistingmrimagingmarkers
AT herrmannfrancoisr alzheimerresemblanceatrophyindexbrainageandnormalpressurehydrocephalusscoreinthepredictionofsubtlecognitivedeclineaddedvaluecomparedtoexistingmrimagingmarkers
AT hedderichdennis alzheimerresemblanceatrophyindexbrainageandnormalpressurehydrocephalusscoreinthepredictionofsubtlecognitivedeclineaddedvaluecomparedtoexistingmrimagingmarkers
AT gaserchristian alzheimerresemblanceatrophyindexbrainageandnormalpressurehydrocephalusscoreinthepredictionofsubtlecognitivedeclineaddedvaluecomparedtoexistingmrimagingmarkers
AT kellnerelias alzheimerresemblanceatrophyindexbrainageandnormalpressurehydrocephalusscoreinthepredictionofsubtlecognitivedeclineaddedvaluecomparedtoexistingmrimagingmarkers
AT rodriguezcristelle alzheimerresemblanceatrophyindexbrainageandnormalpressurehydrocephalusscoreinthepredictionofsubtlecognitivedeclineaddedvaluecomparedtoexistingmrimagingmarkers
AT hallersven alzheimerresemblanceatrophyindexbrainageandnormalpressurehydrocephalusscoreinthepredictionofsubtlecognitivedeclineaddedvaluecomparedtoexistingmrimagingmarkers